Used in targeted protein degradation research, it serves as a key component in PROTAC (Proteolysis Targeting Chimeras) molecules. It facilitates the selective degradation of specific proteins by recruiting E3 ubiquitin ligases, aiding in the study of protein function and disease mechanisms.

Applied in cancer research to degrade oncogenic proteins, it offers potential therapeutic strategies. Also utilized in chemical biology to explore protein-protein interactions and cellular pathways.

Its role in degrading disease-related proteins makes it valuable for drug discovery and development.